FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

16699811000001108: Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Apr 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58695401000001114 Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58695501000001113 Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Is a Ondansetron 8mg tablets 10 tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has AMP Ondansetron 8mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start